WAM
JAZZ icon

Wolverine Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Wolverine Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-45,000
Closed -$6.58M – 1522
2017
Q3 		$6.58M Hold
45,000
– – 0.07% 208
2017
Q2 		$7M Buy
+45,000
New +$6.88M 0.09% 189

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Wolverine Asset Management's JAZZ Position: Q1 2026 in Review

Wolverine Asset Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 1,322 shares worth $250K. The position accounts for ﹤0.01% of the portfolio, ranked #1059.

Wolverine Asset Management first reported a position in JAZZ in Q1 2020 and has held it in 12 quarters since. The position peaked at $1.69M in Q2 2024. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Wolverine Asset Management held 1,322 shares of Jazz Pharmaceuticals worth $250K as of Q1 2026.
  • Wolverine Asset Management left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Wolverine Asset Management's portfolio in Q1 2026, its #1059 holding.
  • Wolverine Asset Management first reported a position in Jazz Pharmaceuticals in Q1 2020 and has held it in 12 quarters since.
  • Wolverine Asset Management's Jazz Pharmaceuticals position peaked at $1.69M in Q2 2024.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.